Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
0.374
+0.013 (3.57%)
At close: Apr 28, 2026, 4:00 PM EDT
0.372
-0.002 (-0.59%)
After-hours: Apr 28, 2026, 4:23 PM EDT
Autonomix Medical Employees
As of March 31, 2025, Autonomix Medical had 11 total employees, including 8 full-time and 3 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$1,567,273
Market Cap
4.33M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 11 | 3 | 37.50% |
| Mar 31, 2024 | 8 | 4 | 100.00% |
| Mar 31, 2023 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Co-Diagnostics | 115 |
| Beyond Air | 61 |
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| Tivic Health Systems | 52 |
| Nuwellis | 38 |
| Catheter Precision | 22 |
| HeartSciences | 15 |
AMIX News
- 6 days ago - Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026 - GlobeNewsWire
- 20 days ago - Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026 - GlobeNewsWire
- 6 weeks ago - Autonomix Medical to Present at LSI USA '26 - GlobeNewsWire
- 7 weeks ago - Autonomix Medical Selected for Best Innovation Competition at CRT 2026 - GlobeNewsWire
- 7 weeks ago - Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis - GlobeNewsWire
- 2 months ago - Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation - GlobeNewsWire
- 2 months ago - Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation - GlobeNewsWire
- 3 months ago - Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium - GlobeNewsWire